Real-time enrollment status for this bladder cancer clinical trial
Current Status
Recruiting
Checked: July 16, 2026 at 8:40 PM UTC
| NCT Number | NCT05316155 |
| Recruiting Status | Recruiting |
| Condition | Bladder Cancer |
| Phase | PHASE1 |
| Target Enrollment | 235 participants |
| Active Locations | 25 sites in the US |
| Sponsor | Janssen Research & Development, LLC |
| Last Updated on CT.gov | June 5, 2026 (Jun 5, 2026) |
As of July 16, 2026: Clinical trial NCT05316155 is currently recruiting participants. This phase1 study for bladder cancer is actively seeking new participants at 25 locations across the United States. The study is sponsored by Janssen Research & Development, LLC. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05316155 is actively recruiting participants as of July 16, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 25 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05316155 was last updated Jun 5, 2026 (June 5, 2026). HelloStudys verifies this status automatically.